Market penetration and forecasting provides vital input into decisions affecting sales, capital outlays, budgeting, inventory control, production scheduling, marketing strategies and financial planning. We at Lifescience Dynamics, we specialise in long term new compound forecasting. We have developed propriety quantitative methods for incorporating market research data and modelling the impact of future launches, loss of patents, price discount or increase, new indication; that results into model outputs. Our market modelling and forecasting practice specialty has a diverse range of expertise, including strong analytical and quantitative skills, to provide the following key specialised services to the pharmaceutical and biotech industries:

• Quick turnaround, Epidemiology (secondary data) driven and patient-based forecast
  
  
• Epidemiology (primary data) driven and patient-based forecast
  
  
• Launch of new drug in established market by reconciling epidemiology data, IMS sales data, time series analysis, and the impact of future events
  
  
• Forecast the uptake of therapeutic categories using the Bass Model - one of the most studied and cited marketing model
  
  
• Forecast the impact of advertising and promotion with econometric models
  
  
• Forecast the impact of product profile with conjoint-type models
  
  
• Forecast the impact of generic competition
  
  
• Total therapeutic category forecast with class competition and cannibalisation
  
  
• Scenario planning and simulation forecast modelling for modelling 'What-if' analysis